Trial Profile
Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Heart disorders
- Focus Therapeutic Use
- 17 Jan 2012 Planned end date changed from 1 Jun 2012 to 1 Sep 2011 as reported by ClinicalTrials.gov.
- 17 Jan 2012 Actual patient number is 20 according to ClinicalTrials.gov.
- 17 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.